CAG vs KYTX · P/E 31, rev $11.28B vs $488.8M cap
ConAgra Foods Inc (CAG) versus Kyverna Therapeutics, Inc. Common Stock (KYTX) — a side-by-side from cached financials, not a winner call.
ConAgra Foods Inc (CAG) is a packaged foods company listed on US.
Kyverna Therapeutics, Inc. Common Stock (KYTX) is a biotechnology company listed on NASDAQ.
Latest reported CAG revenue for 2026-05-31 was $11.28B. Net income was -$1.92B. Revenue was down 2.9% from 2025-05-25 to 2026-05-31. CAG currently screens at market cap $10.02B and trailing P/E 30.9.
KYTX does not have a complete income-statement cache yet.
CAG currently screens at market cap $10.02B and trailing P/E 30.9. KYTX currently screens at market cap $488.8M.
Not investment advice. Open the CAG and KYTX stock pages for the full models.
Not investment advice.